Structure and Properties of Dinuclear Manganese(III) Complexes with Pentaanionic Pentadentate Ligands Including Alkoxo, Amido, and Phenoxo Donors
详细信息 查看全文
- 作者：Liliana Stoicescu ; Auré ; lie Jeanson ; Carine Duhayon ; Ana Tesouro-Vallina ; Athanassios K. Boudalis ; Jean-Pierre Costes ; Jean-Pierre Tuchagues
- 刊名：Inorganic Chemistry
- 出版年：2007
- 出版时间：August 20, 2007
- 年：2007
- 卷：46
- 期：17
- 页码：6902 - 6910
- 全文大小：262K
- 年卷期：v.46,no.17(August 20, 2007)
- ISSN：1520-510X
文摘
Doubly bridged 
-alkoxo--X (X = pyrazolato or acetato) dinuclear MnIII complexes of 2-hydroxy-N-{2-hydroxy-3-[(2-hydroxybenzoyl)amino]propyl}benzamide) (H5L1) and 2-hydroxy-N-{2-hydroxy-4-[(2-hydroxybenzoyl)amino]butyl}benzamide (H5L2), [Mn2(L)(pz)(MeOH)4]·xMeOH (1, L = L1, x = 0.5; 2, L = L2, x = 0; Hpz = pyrazole) and[Mn2(L1)(OAc)(MeOH)4] (3), have been prepared, and their structure and magnetic properties have been studied.The X-ray diffraction analysis of 1 (C24.5H34Mn2N4O9.5, triclinic, P
, a = 12.2050(7) Å, b = 12.7360(8) Å, c =19.2780(10) Å, 
= 99.735(5)
, 
= 96.003(4), 
= 101.221(5), V = 2867.6(3) Å3, Z = 4), 2 (C25H34Mn2N4O9,triclinic, P, a = 9.4560(5) Å, b = 11.0112(5) Å, c = 13.8831(6) Å, = 90.821(4), = 92.597(4), =93.403(4), V = 1441.29(12) Å3, Z = 2), and 3 (C23H32Mn2N2O11, triclinic, P, a = 10.511(5) Å, b = 11.713(5) Å,c = 13.135(5) Å, = 64.401(5), = 74.000(5), = 66.774(5), V = 1329.3(10) Å3, Z = 2) revealed that allcomplexes consist of dinuclear units which are further extended into 1D (1 and 3) and 2D (2) supramolecularnetworks via hydrogen-bonding interactions. Magnetic susceptibility data evidence antiferromagnetic interactionsfor all three complexes: J = -3.6 cm-1, D 
0 cm-1, g = 1.93 (1); J = -2.7 cm-1, D = 0.8 cm-1, g = 1.93(2); J = -4.9 cm-1, D = 3.8 cm-1, g = 1.95 (3).
-alkoxo--X (X = pyrazolato or acetato) dinuclear MnIII complexes of 2-hydroxy-N-{2-hydroxy-3-[(2-hydroxybenzoyl)amino]propyl}benzamide) (H5L1) and 2-hydroxy-N-{2-hydroxy-4-[(2-hydroxybenzoyl)amino]butyl}benzamide (H5L2), [Mn2(L)(pz)(MeOH)4]·xMeOH (1, L = L1, x = 0.5; 2, L = L2, x = 0; Hpz = pyrazole) and[Mn2(L1)(OAc)(MeOH)4] (3), have been prepared, and their structure and magnetic properties have been studied.The X-ray diffraction analysis of 1 (C24.5H34Mn2N4O9.5, triclinic, P, a = 12.2050(7) Å, b = 12.7360(8) Å, c =19.2780(10) Å, = 99.735(5), = 96.003(4), = 101.221(5), V = 2867.6(3) Å3, Z = 4), 2 (C25H34Mn2N4O9,triclinic, P, a = 9.4560(5) Å, b = 11.0112(5) Å, c = 13.8831(6) Å, = 90.821(4), = 92.597(4), =93.403(4), V = 1441.29(12) Å3, Z = 2), and 3 (C23H32Mn2N2O11, triclinic, P, a = 10.511(5) Å, b = 11.713(5) Å,c = 13.135(5) Å, = 64.401(5), = 74.000(5), = 66.774(5), V = 1329.3(10) Å3, Z = 2) revealed that allcomplexes consist of dinuclear units which are further extended into 1D (1 and 3) and 2D (2) supramolecularnetworks via hydrogen-bonding interactions. Magnetic susceptibility data evidence antiferromagnetic interactionsfor all three complexes: J = -3.6 cm-1, D 0 cm-1, g = 1.93 (1); J = -2.7 cm-1, D = 0.8 cm-1, g = 1.93(2); J = -4.9 cm-1, D = 3.8 cm-1, g = 1.95 (3).